Next Article in Journal
Magnetic Multi-Enzymatic System for Cladribine Manufacturing
Next Article in Special Issue
Roles and Mechanisms of Long Non-Coding RNAs in Breast Cancer
Previous Article in Journal
Vulnerable Atherosclerotic Plaque: Is There a Molecular Signature?
Previous Article in Special Issue
Androgen-Responsive Oncogenic lncRNA RP11-1023L17.1 Enhances c-Myc Protein Stability in Prostate Cancer
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
IJMS
Volume 23
Issue 21
10.3390/ijms232113637
Review Report
ijms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Review
Peer-Review Record

Extracellular Vesicle (EVs) Associated Non-Coding RNAs in Lung Cancer and Therapeutics

Int. J. Mol. Sci. 2022, 23(21), 13637; https://doi.org/10.3390/ijms232113637
by Anjugam Paramanantham 1, Rahmat Asfiya 1, Siddharth Das 1, Grace McCully 1 and Akhil Srivastava 1,2,*
Reviewer 1:
Faisal Alzahrani
Reviewer 2: Anonymous
Int. J. Mol. Sci. 2022, 23(21), 13637; https://doi.org/10.3390/ijms232113637
Submission received: 12 October 2022 / Revised: 25 October 2022 / Accepted: 26 October 2022 / Published: 7 November 2022
(This article belongs to the Special Issue Non-coding RNAs in Cancer, Aging and Regeneration)

Round 1

Reviewer 1 Report

From my point of view, this study was well written and gave a comprehensive overview of the diagnostic and therapeutic applications of extracellular vesicles in lung cancer. Also the sequence and transition from one topic to another was great. Also a good thing about the study was the authors' emphasis on taking into account the recommendations of the International Society of Extracellular Vesicles. I may have some comments that do not affect the quality of the manuscript. First, I think that the author used a large part of the review to talk about general and basic information not directly related to the topic of the research, but to the biology of exosomes. Another point, in the discussion section, I suggest that the authors answer two important points. First, we are at a stage where we cannot be certain about the mentioned effects of microRNA. Because most studies focus on the effect of these components on a specific tissue without ensuring the safety of the rest of the body's other tissues. Second, we cannot be certain that the components found in body fluids are exclusively present in the exosome, which makes it difficult for us to determine the reality of the effect. 

 

On line 544, you need to give a reference.

Authors should mention the software used to produce the images

 

 

Author Response

Please see the attachment

Author Response File: Author Response.pdf

Reviewer 2 Report

The recommendations for improvement are listed below:

1. For the RNA binding protein/translocation of RNA to exosomes, the author just mentioned one of the RNPs, SYNCRIP, there are several RNPs have been found for RNA sorting into exosomes, such as YBX1 and Lupus La. It would make this part of the summary more complete if other RNPs were added.

2. For the 3.1.1, it would be better to make a table to show which miRNA was upregulated or downregulated in exosomes from different lung cancer samples.

 

3. Line323-324, this sentence is not complete.

Author Response

Please see the attachment

Author Response File: Author Response.pdf

Back to TopTop